Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of Langerhans
cell histiocytosis, either by killing the cells or by stopping them from dividing. Giving
more than one drug (combination chemotherapy) may be an effective treatment for Langerhans
cell histiocytosis.
PURPOSE: This randomized clinical trial is studying combination chemotherapy to see how well
it works in treating young patients with Langerhans cell histiocytosis.